<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis</title>
				<funder ref="#_Ut8gGjB">
					<orgName type="full">Howard Hughes Medical Institute</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher>Springer Science and Business Media LLC</publisher>
				<availability status="unknown"><p>Copyright Springer Science and Business Media LLC</p>
				</availability>
				<date type="published" when="2010-07-07">2010 July 7.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Jennifer</forename><forename type="middle">C</forename><surname>King</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Human Oncology and Pathogenesis Program</orgName>
								<orgName type="institution">Memorial Sloan-Kettering Cancer Center</orgName>
								<address>
									<addrLine>1275 York Avenue</addrLine>
									<postCode>10065</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jin</forename><surname>Xu</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Human Oncology and Pathogenesis Program</orgName>
								<orgName type="institution">Memorial Sloan-Kettering Cancer Center</orgName>
								<address>
									<addrLine>1275 York Avenue</addrLine>
									<postCode>10065</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">John</forename><surname>Wongvipat</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Human Oncology and Pathogenesis Program</orgName>
								<orgName type="institution">Memorial Sloan-Kettering Cancer Center</orgName>
								<address>
									<addrLine>1275 York Avenue</addrLine>
									<postCode>10065</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Haley</forename><surname>Hieronymus</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Human Oncology and Pathogenesis Program</orgName>
								<orgName type="institution">Memorial Sloan-Kettering Cancer Center</orgName>
								<address>
									<addrLine>1275 York Avenue</addrLine>
									<postCode>10065</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Brett</forename><forename type="middle">S</forename><surname>Carver</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Human Oncology and Pathogenesis Program</orgName>
								<orgName type="institution">Memorial Sloan-Kettering Cancer Center</orgName>
								<address>
									<addrLine>1275 York Avenue</addrLine>
									<postCode>10065</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">David</forename><forename type="middle">H</forename><surname>Leung</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Human Oncology and Pathogenesis Program</orgName>
								<orgName type="institution">Memorial Sloan-Kettering Cancer Center</orgName>
								<address>
									<addrLine>1275 York Avenue</addrLine>
									<postCode>10065</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Barry</forename><forename type="middle">S</forename><surname>Taylor</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Computational and Systems Biology Center</orgName>
								<orgName type="institution">Memorial Sloan-Kettering Cancer Center</orgName>
								<address>
									<addrLine>1275 York Avenue</addrLine>
									<postCode>10065</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Physiology and Biophysics</orgName>
								<orgName type="institution">Weill Medical College of Cornell University</orgName>
								<address>
									<postCode>10065</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Chris</forename><surname>Sander</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Computational and Systems Biology Center</orgName>
								<orgName type="institution">Memorial Sloan-Kettering Cancer Center</orgName>
								<address>
									<addrLine>1275 York Avenue</addrLine>
									<postCode>10065</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Robert</forename><forename type="middle">D</forename><surname>Cardiff</surname></persName>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Center for Comparative Medicine</orgName>
								<orgName type="department" key="dep2">Department of Pathology and Laboratory Medicine</orgName>
								<orgName type="institution">University of California</orgName>
								<address>
									<postCode>95616</postCode>
									<settlement>Davis</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Suzana</forename><forename type="middle">S</forename><surname>Couto</surname></persName>
							<affiliation key="aff4">
								<orgName type="laboratory">Laboratory of Comparative Pathology</orgName>
								<orgName type="institution">Memorial Sloan-Kettering Cancer Center</orgName>
								<address>
									<addrLine>1275 York Avenue</addrLine>
									<postCode>10065</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">William</forename><forename type="middle">L</forename><surname>Gerald</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Human Oncology and Pathogenesis Program</orgName>
								<orgName type="institution">Memorial Sloan-Kettering Cancer Center</orgName>
								<address>
									<addrLine>1275 York Avenue</addrLine>
									<postCode>10065</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Charles</forename><forename type="middle">L</forename><surname>Sawyers</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Human Oncology and Pathogenesis Program</orgName>
								<orgName type="institution">Memorial Sloan-Kettering Cancer Center</orgName>
								<address>
									<addrLine>1275 York Avenue</addrLine>
									<postCode>10065</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="institution" key="instit1">Howard Hughes Medical Institute</orgName>
								<orgName type="institution" key="instit2">Memorial Sloan-Kettering Cancer Center</orgName>
								<address>
									<addrLine>1275 York Avenue</addrLine>
									<postCode>10065</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Nature Genetics</title>
						<title level="j" type="abbrev">Nat Genet</title>
						<idno type="ISSN">1061-4036</idno>
						<idno type="eISSN">1546-1718</idno>
						<imprint>
							<publisher>Springer Science and Business Media LLC</publisher>
							<biblScope unit="volume">41</biblScope>
							<biblScope unit="issue">5</biblScope>
							<biblScope unit="page" from="524" to="526"/>
							<date type="published" when="2010-07-07">2010 July 7.</date>
						</imprint>
					</monogr>
					<idno type="MD5">19DDC72AE428768C54BED1E648CB982D</idno>
					<idno type="DOI">10.1038/ng.371</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.0" ident="GROBID" when="2025-04-21T20:05+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>The TMPRSS2-ERG fusion, present in 50% of prostate cancers, is less common in prostatic intraepithelial neoplasia (PIN), raising questions about whether TMPRSS2-ERG contributes to disease initiation.</s><s>We identified the translational start site of a common TMPRSS2-ERG fusion and showed that transgenic TMPRSS2-ERG mice develop PIN, but only in the context of PI3-kinase pathway activation.</s><s>TMPRSS2-ERG positive human tumors are also enriched for PTEN loss, suggesting cooperation in prostate tumorigenesis.</s></p><p><s>Recurrent gene fusions involving members of the ETS family of transcription factors occur frequently in human prostate cancer 1 .</s><s>The TMPRSS2-ERG fusion gene, generated by an intrachromosomal deletion on chromosome 21 or by reciprocal translocation, is the most common rearrangement, found in ~50% of localized tumors 1 .</s><s>The fusion is detected in essentially all the malignant cells within a focus of tumor, supporting a role in disease initiation.</s><s>However, TMPRSS2-ERG is less commonly found in preneoplastic PIN lesions and, when present, is typically in PIN adjacent to fusion-positive tumor cells 2 .</s><s>Potential explanations for the relatively low frequency of TMPRSS2-ERG in PIN versus cancer are: (i) TMPRSS2-ERG is not an initiating event, (ii) PIN may not be a reliable precursor lesion to invasive cancer, or (iii) PIN is molecularly heterogeneous but TMPRSS2-ERG driven PIN progresses rapidly to cancer.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>We addressed this question by generating transgenic mice expressing the TMPRSS2-ERG fusion in the prostate.</s><s>Two ERG isoforms (variants 1 and 2) have been characterized, which differ in the N terminus as well as the presence of a downstream ERG exon due to alternative splicing.</s><s>We designed our TMPRSS2-ERG construct (Fig. <ref type="figure" target="#fig_0">1a</ref>) to re-create the most common translocation breakpoints 3 and used the variant 2 ERG isoform based on exon array expression profiling data showing relative abundance of variant 2 in TMPRSS2-ERG positive human tumors <ref type="bibr" target="#b3">4</ref> .</s><s>Due to N-terminal truncation of ERG and fusion to non-coding TMPRSS2 sequence, the initiating methionine for ERG translation is removed, raising questions about the translational start site of TMPRSS2-ERG fusion mRNA.</s><s>To address this issue, we conducted mass spectrometry analysis of the protein product of our TMPRSS2-ERG fusion (Fig. <ref type="figure" target="#fig_0">1c</ref>, lane 4) and recovered five tryptic peptides.</s><s>The most N-terminal peptide spanned amino acids 58-70 of ERG (nucleotides 358-396), narrowing down the possible start codon to the methionine encoded by nucleotide 304 (Met 40 in full length ERG) or to Met 54 at nucleotide 356 (Fig. <ref type="figure" target="#fig_0">1b</ref>).</s><s>Mutation of the ATG encoding Met 40 to AAG substantially impaired translation of the TMPRSS2-ERG protein (Fig <ref type="figure" target="#fig_0">1c</ref>, compare lanes 4 and 5) and, in the context of full length ERG, eliminated expression of the faster migrating ERG isoform observed with wild-type ERG overexpression (Fig. <ref type="figure" target="#fig_0">1c</ref>, compare lanes 2 and 3).</s><s>These data implicate Met 40 as the principle start site for ERG expression in the TMPRSS2-ERG fusion as well as a potential alternative start site for wild-type ERG expression.</s></p><p><s>To create transgenic mice, we placed the TMPRSS2-ERG fusion construct under the control of the ARR 2 -Probasin promoter, used in previous models of PIN and prostate cancer <ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref> .</s><s>Seventeen transgene-positive founder animals were generated by injection of the ARR 2 -PB-TMPRSS2-ERG construct into FVB blastocysts (Fig. <ref type="figure" target="#fig_0">1d</ref>) and four demonstrated stable germline transmission of the transgene.</s><s>Two lines (43 and 44) were expanded based on robust transgene expression at levels 20-fold greater than endogenous mouse Erg (Fig. <ref type="figure" target="#fig_0">1e</ref>) and comparable to levels observed in an independently derived mouse expressing full length ERG variant 1 <ref type="bibr" target="#b7">8</ref> .</s><s>Prostates from TMPRSS2-ERG fusion mice from both lines were harvested at 2, 6, 12 and 14 months and compared with littermate controls.</s><s>We found no histologic evidence of PIN or invasive cancer in 18 TMPRSS2-ERG mice examined (Fig. <ref type="figure" target="#fig_1">2a</ref>).</s><s>Although mild dysplasia was seen in some transgene-positive mice, these changes are commonly observed in wild-type mice and cannot be definitively attributed to transgene expression.</s></p><p><s>These data suggest that TMPRSS2-ERG is insufficient to initiate prostate neoplasia and that cooperating oncogenic lesions are required.</s><s>Two relatively common abnormalities in human prostate cancer are PTEN loss and MYC amplification, both of which play pathogenic roles in genetically engineered mouse models <ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b8">9</ref> .</s><s>We therefore examined a cohort of TMPRSS2-ERG positive and negative human prostate tumors (n=121) for associated PTEN copy number loss or MYC amplification as measured by high resolution array-based comparative genome hybridization (aCGH).</s><s>TMPRSS2-ERG status was determined based on interstitial deletion by aCGH and by exon array based mRNA expression profiling, which is highly correlated with fluorescent in situ hybridization analysis <ref type="bibr" target="#b9">10</ref> .</s><s>Although PTEN inactivation can also occur through loss of expression or point mutation, we determined PTEN status in these tumors by copy number alteration as this is a common mechanism of PTEN loss and provides robust evidence of gene inactivation.</s><s>Tumors with PTEN loss were highly enriched for ERG rearrangement (p-value&lt;0.002,</s><s>Fisher's one-sided exact test, Fig. <ref type="figure" target="#fig_1">2b</ref> and Supplementary Tables <ref type="table">1</ref><ref type="table">2</ref><ref type="table">3</ref><ref type="table">4</ref><ref type="table">5</ref>), consistent with a similar association between reduced PTEN expression (measured by immunohistochemistry) and ERG fusion <ref type="bibr" target="#b7">8</ref> .</s><s>These studies are meaningful in light of a recent report that concurrent ERG rearrangement and PTEN loss in human prostate cancers predicts earlier disease recurrence <ref type="bibr" target="#b10">11</ref> .</s><s>In contrast, c-MYC amplification was not associated with ERG rearrangement (p-value=0.56,</s><s>Fig. <ref type="figure" target="#fig_1">2c</ref>).</s><s>However, increased c-MYC mRNA levels, as measured by exon array, were associated with ERG rearrangement (p-value=0.0465,</s><s>data not shown), consistent with recent evidence that c-MYC is a transcriptional target of TMPRSS2-ERG <ref type="bibr" target="#b11">12</ref> .</s><s>Taken together, these data establish that PTEN loss occurs in cooperation with TMPRSS2-ERG fusion, however ERG rearrangement does not result in selective pressure for MYC amplification.</s></p><p><s>To test the biological significance of the PTEN/TMPRSS2-ERG association in human tumors, we crossed our TMPRSS2-ERG mice with Pten +/-mice <ref type="bibr" target="#b8">9</ref> .</s><s>At six months of age, all compound mice examined (8 of 8)showed clear histologic evidence of PIN (Fig <ref type="figure" target="#fig_1">2d</ref>).</s><s>Notably, one Pten+/-; TMPRSS2-ERG animal had areas suggestive of microinvasive disease with attenuation of the periglandular smooth muscle stroma as well as stromal reaction, and inflammation around affected glands (Fig. <ref type="figure" target="#fig_1">2e</ref> , Supplementary Figure <ref type="figure" target="#fig_0">1</ref>).</s><s>A focus of low grade PIN was observed in only 1 out of 8 Pten +/-littermate controls where the incidence of PIN at this age is reported to be about 10 percent <ref type="bibr" target="#b8">9</ref> .</s><s>To further explore the interaction with the PI3K pathway, we crossed TMPRSS2-ERG mice with prostate-specific AKT transgenic mice, which develop low grade PIN but do not progress to invasive cancer even at advanced age <ref type="bibr" target="#b6">7</ref> .</s><s>In contrast to 8 transgenic AKT littermate controls, 8 of 8 bigenic mice examined had developed more florid lesions by 10-12 months of age (Fig. <ref type="figure" target="#fig_1">2f</ref>).</s><s>We also crossed our TMPRSS2-ERG mice to ARR2PB-c-MYC (Hi-Myc) transgenic mice <ref type="bibr" target="#b4">5</ref> and found no evidence of cooperativity in 8 mice at 3 or 6 months, after which nearly all Hi-Myc mice have developed invasive cancer (Supplementary Figure <ref type="figure" target="#fig_1">2</ref>).</s><s>This result is consistent with the failure to detect significant coincidence of TMPRSS2-ERG fusion and c-MYC amplification in human tumors.</s></p><p><s>Our finding that TMPRSS2-ERG alone is insufficient to induce prostate neoplasia (or PIN) is in agreement with an independent study published in this issue <ref type="bibr" target="#b7">8</ref> but contrasts with two other reports that transgenic ERG expression induces PIN at 3-6 months of age <ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b13">14</ref> .</s><s>These discrepancies are unlikely related to levels of transgene expression.</s><s>All four models used the ARR2-Pb promoter, and our mice express the transgene at levels comparable to Carver et al. (Fig. <ref type="figure" target="#fig_0">1e</ref>) and Klezovitch et al. (data not shown).</s><s>Our mice differ in the inclusion of upstream untranslated TMPRSS2 sequences in the ERG fusion (which may impact translational efficiency, although we have no evidence for this based on transfection experiments) and the use of the variant 2 ERG isoform, which is an abundant allele in human tumors.</s><s>The difference may lie in interpretation of mouse prostate histology, as the changes reported by Klezovitch et al. and by Tomlins et al. are subtle in comparison to the PIN phenotypes seen in other mouse prostate cancer models 13, 14.</s><s>The higher frequency of microinvasion in the ERG;Pten +/-mice in the accompanying report may relate to mouse background because PI3K pathway activation induces a greater degree of proliferation, as measured by Ki-67 staining, in C57BL/6 (Carver et al.) relative to FVB (our model) <ref type="bibr" target="#b14">15</ref> .</s><s>Collectively, these data establish cooperativity between PI3K pathway activation and ERG aberration in induction of PIN but suggest that additional events are likely required for actual malignancy.</s><s>Comprehensive human prostate cancer oncogenome studies are needed to fully annotate the frequency of alterations in these and other pathways.</s></p><p><s>discussions.</s><s>We also thank Pier Paolo Pandolfi for sharing unpublished results and Valera Vasioukhin for providing transgenic prostate lobes.</s><s>TMPRSS2-ERG fusion and PI3K pathway activation are cooperative events in prostate cancer.</s><s>All pictures show the ventral prostate lobe.</s><s>a, No PIN is noted in either wild type or TMPRSS2-ERG animals at 12 months of age (H&amp;E, 200X).</s><s>b, The proportion of human prostate cancers that show PTEN genomic loss, ERG rearrangement, both, or neither are shown (n = 121).</s><s>PTEN loss was defined as having reduced copy number by RAE (heterozygous or homozygous loss; FDR q-value&lt;6.93×10 -</s><s> ).</s><s>ERG rearrangement was defined as the consequence of interstitial deletion by aCGH (q-value&lt;6.93×10 -</s><s> ) and increased expression of ERG downstream of common translocation breakpoints (exons 5-8) relative to early ERG exons (exons 1-2) [&gt;2 s.d.</s><s>above the mean of normal samples (n=29) by exon expression array] The significance of the association between PTEN loss and ERG rearrangement is p-value&lt;0.002</s><s>as determined by Fisher's exact test (right tail).</s><s>c, The proportion of human prostate cancers that show MYC genomic amplification, ERG rearrangement, both, or neither are shown (n = 121).</s><s>MYC amplification was defined as having increased copy number (q-value&lt;1.2×10 <ref type="bibr">-7</ref> ).</s><s>ERG rearrangement and the significance of association (p-value=0.56)</s><s>was defined as in</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 .</head><label>1</label><figDesc><div><p><s>Fig. 1.</s><s>TMPRSS2-ERG fusion transcript produces a truncated ERG protein product.</s><s>a, Diagram of TMPRSS2-ERG variant 2 construct.</s><s>b, Tryptic peptides recovered from mass spectrometry performed on immunoprecipitated, gel-resolved protein from the fusion construct.</s><s>c, ERG immunoblot of transiently transfected vector control, full length ERG, full length ERG with codon 304 mutation, fusion, or fusion with the codon 304 mutation.</s><s>A diagram showing the protein products derived from the non-mutated constructs is shown on the right.</s><s>d, Southern blot showing founder animals derived from blastocyst injections of ARR2PB-TMPRSS2-ERG construct.</s><s>DNA was cut with BamHI and probed with a BamHI fragment that encodes the first 1050bp of the fusion.</s><s>e, qRT-PCR using primers for the C-terminus of ERG on</s></p></div></figDesc><graphic coords="5,147.74,61.00,376.51,503.94" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2 .</head><label>2</label><figDesc><div><p><s>Fig. 2.</s></p></div></figDesc><graphic coords="7,84.01,61.00,503.98,445.66" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc><div><p><s>Fig 2b.</s><s>d, Normal prostate in Pten +/-and high grade PIN in Pten +/-; TMPRSS2-ERG mice at 6 months of age (H&amp;E, 200X).</s><s>Arrows indicate PIN and arrowheads show normal epithelium for comparison.</s><s>e, Immunohistochemistry for smooth muscle actin in a Pten +/-and a Pten +/-; TMPRSS2-ERG mouse (400X).</s><s>Compare disrupted and absent smooth muscle stroma around areas of possible microinvasion from a Pten +/-; TMPRSS2-ERG mouse (right column, arrows) to minimally attenuated smooth muscle sheath around area of high grade PIN in Pten +/-(left column, arrows) and to intact stroma of normal glands in both animals.</s><s>f, Low grade PIN in AKT transgenic mice and high grade PIN in AKT; TMPRSS2-ERG double transgenic animals at 11 months of age (H&amp;E, 400X).</s><s>Arrows indicate PIN and arrowheads show normal epithelium for comparison.</s></p></div></figDesc></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p><s>Nat Genet.</s><s>Author manuscript; available in PMC 2010 July 7.</s></p></note>
		</body>
		<back>

			<div type="acknowledgement">
<div><head>Acknowledgments</head><p>This work was supported by a <rs type="person">Ruth L. Kirschstein NRSA</rs> (<rs type="grantNumber">7F32CA113132</rs>) to J.C.K. C.L.S. is an Investigator of the <rs type="funder">Howard Hughes Medical Institute</rs> and a Doris Duke Distinguished Clinical Scholar.B.S.T is a fellow of the <rs type="institution">Geoffrey Beene Cancer Research Center at MSKCC</rs>.We thank <rs type="person">Kate Yen</rs>, <rs type="person">Nicola Clegg</rs>, <rs type="person">Yu Chen</rs>, <rs type="person">Tambudzai Shamu</rs>, and the <rs type="institution">MSKCC CMG, Proteomics</rs>, and <rs type="person">Molecular Cytology Core Facilities</rs> for technical help and/or</p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_Ut8gGjB">
					<idno type="grant-number">7F32CA113132</idno>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supplementary Material</head><p><s>Refer to Web version on PubMed Central for supplementary material.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">C</forename><surname>Kumar-Sinha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Tomlins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Chinnaiyan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Cancer</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="497" to="511" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 18563191</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Perner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Surg Pathol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="882" to="888" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17527075</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Tomlins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">310</biblScope>
			<biblScope unit="page" from="644" to="648" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>PubMed: 16254181</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Jhavar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Diagn</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">18165275</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">Ellwood-Yen K</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Cell</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="223" to="238" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>PubMed: 14522256</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">Z</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kasper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Matusik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="4698" to="4710" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note>PubMed: 11108285</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Majumder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="7841" to="7846" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>PubMed: 12799464</note>
</biblStruct>

<biblStruct xml:id="b7">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Carver</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2009">2009</date>
			<publisher>In Press</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">Di</forename><surname>Cristofano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pesce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Cordon-Cardo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pandolfi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="348" to="355" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note>PubMed: 9697695</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">G</forename><surname>Attard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="253" to="263" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 17637754</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">M</forename><surname>Yoshimoto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mod Pathol</title>
		<imprint>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">C</forename><surname>Sun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="5348" to="5353" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 18542058</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">O</forename><surname>Klezovitch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="2105" to="2110" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 18245377</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Tomlins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neoplasia</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="177" to="188" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 18283340</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">Q</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="17771" to="17776" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17978178</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
